Skip to main content
. 2013 Mar;15(2):270–279. doi: 10.1016/j.jmoldx.2012.11.002

Figure 5.

Figure 5

Kaplan-Meier analysis of BCR-free survival in 523 prostate cancer patients stratified by the DNA methylation status of PITX2. Methylation cut-off for patient stratification was applied as established above.